When entering China’s healthcare market, digital solution providers quickly realize that regulatory, data, and market access barriers are just as critical as performance. AI-assisted medical imaging and remote diagnostics offer significant opportunities if pursued with the right localization, compliance, and partnership strategies, whereas areas such as cloud-based patient data processing remain heavility restricted.
On September 25, we’re diving into the real-world pathways (and roadblocks) for scaling AI solutions in China’s healthcare sector — from regulatory hurdles to partnership strategies.
Featuring Chenchao Liu, MD of SILREAL, in conversation with Erik Walenza, CEO of Asia Growth Partners.
Sep 25 | 15:00–16:00 CN/SG | 9:00–10:00 CET 📍 MS Teams
“Invite-Only” for IT + Business + Operations managers interested in scaling AI
